The U.S. Food and Drug Administration (FDA) has granted approval to Sebelas Miudella™, marking the first hormone-free intrauterine device (IUD) to receive regulatory clearance in 40 years. This milestone offers a long-acting, non-hormonal birth control option for individuals seeking alternatives to hormonal contraception.

Designed for efficacy and biocompatibility, Sebelas Miudella™ provides a low-maintenance, long-term contraceptive solution, addressing the growing demand for hormone-free reproductive choices. The approval underscores a shift toward expanded contraceptive options, empowering individuals with more diverse and personalized family planning methods.